What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.
Yutrepia was well tolerated and improved 6-minute walk distance and cardiac effort at 16 weeks in patients with pulmonary ...
Farmers are meticulous about all sorts of monitoring but many still overlook the quality of the water they use in irrigation ...
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...